Aramark ARMK Payment for Contingent Consideration Liability, Financing Activities

Payment for Contingent Consideration Liability, Financing Activities at other companies

Axsome TherapeuticsAXSM

-$3.26M-42.8%

Stifel FinancialSF

$57K-55.5%

Jones Lang LaSalleJLL

$8.5M+1,317%

StoneX Group Inc.SNEX

$200K-80.0%

MTZ

MasTecMTZ

$0-100%

MarshMRSH

$31M-3.1%

Other financials

Income statement

See full

Revenue$4.9B+14.7%

Gross profit$426.4M+18.6%

Operating income$219.7M+26.2%

Net income$102.0M+64.8%

EPS (diluted)$0.38+65.2%

Balance sheet

See full

Cash & equivalents$540.8M-44.5%

Total debt$6.5B-10.8%

Total equity$3.3B+8.6%

Total assets$13.8B+2.6%

Cash flow

See full

Operating cash flow-$782.2M-33.2%

CapEx$101.3M-12.5%

Free cash flow-$904.4M-27.9%

Valuation

See full

Market cap$14.02B+37.3%

Enterprise value$20B+19.3%

P/E39.3×+9.9×

P/S0.7×+0.1×

Profitability

See full

Gross margin8.4%-0.1pp

Operating margin4.3%-0.1pp

Net margin1.8%-0.1pp

FCF margin1.2%—

Returns & leverage

See full

Return on equity11.3%-0.4pp

Debt / equity2×-0.4×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Aramark in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Aramark’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aramark's payment for contingent consideration liability, financing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aramark's payment for contingent consideration liability, financing activities?: Aramark (ARMK) reported payment for contingent consideration liability, financing activities of $6.63M in Q1 2026.
How has Aramark's payment for contingent consideration liability, financing activities changed year-over-year?: Aramark's payment for contingent consideration liability, financing activities decreased by 28.8% year-over-year, from $9.3M to $6.63M.